中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
14期
104-105
,共2页
拉莫三嗪%癫痫%丙戊酸钠%临床疗效
拉莫三嗪%癲癇%丙戊痠鈉%臨床療效
랍막삼진%전간%병무산납%림상료효
Lamotrigine%Epilepsy%Valproate%Clinical efficacy
目的：分析拉莫三嗪在癫痫治疗中的应用效果。方法搜集本院神经内科2014年2月～2015年2月诊治的47例癫痫患者，根据使用药物的不同分为两组，甲组采用拉莫三嗪药物，乙组采用丙戊酸钠药物，对比临床疗效。结果（1）甲组患者的治疗总有效率96.0%（24/25）高于乙组81.8%（18/22），P<0.05；（2）甲组患者的癫痫放电减少好于乙组，P<0.05；（3）甲组不良反应的发生率8.0%（2/25）低于乙组22.7%，P<0.05。结论拉莫三嗪治疗癫痫的临床疗效显著，减少患者的发病次数，癫痫得到有效控制。
目的：分析拉莫三嗪在癲癇治療中的應用效果。方法搜集本院神經內科2014年2月～2015年2月診治的47例癲癇患者，根據使用藥物的不同分為兩組，甲組採用拉莫三嗪藥物，乙組採用丙戊痠鈉藥物，對比臨床療效。結果（1）甲組患者的治療總有效率96.0%（24/25）高于乙組81.8%（18/22），P<0.05；（2）甲組患者的癲癇放電減少好于乙組，P<0.05；（3）甲組不良反應的髮生率8.0%（2/25）低于乙組22.7%，P<0.05。結論拉莫三嗪治療癲癇的臨床療效顯著，減少患者的髮病次數，癲癇得到有效控製。
목적：분석랍막삼진재전간치료중적응용효과。방법수집본원신경내과2014년2월～2015년2월진치적47례전간환자，근거사용약물적불동분위량조，갑조채용랍막삼진약물，을조채용병무산납약물，대비림상료효。결과（1）갑조환자적치료총유효솔96.0%（24/25）고우을조81.8%（18/22），P<0.05；（2）갑조환자적전간방전감소호우을조，P<0.05；（3）갑조불량반응적발생솔8.0%（2/25）저우을조22.7%，P<0.05。결론랍막삼진치료전간적림상료효현저，감소환자적발병차수，전간득도유효공제。
Objective Application efficacy of lamotrigine medication in treatment of epilepsy is to be studied.MethodsChose 47 patients of epilepsy who were treated in hospital from February 2014 to February 2015 and separated them into two groups according to different medication treatments,patients in group A are given lamotrigine medication treatment and patients in group B are given valproate medication treatment,and then compared treatment effects between two groups.Results (1)treatment efficacy in group A was up to 96.0%(24/25),which was much higher than 81.8%(18/22)in group B,P< 0.05;(2)patients’ reduction of epilepsy discharge in group A was much better than that in Group B,P< 0.05;(3)side-effect incidence in group A was 8.0%,which was quite less than 22.7% in group B,P< 0.05.Conclusion Lamotrigine medication is of efficacy in treatment of epilepsy and it is conducive to reducing patients’ epilepsy attack and keeping patients’ ilness in control,thus,such a medication treatment is of application value.
